Heart function after severe hemorrhagic shock

Shock

Volumn 12, Issue 6, 1999, Pages 454-461

  Kline, Jeffrey A ^a   Thornton, Lisa R ^a   Lopaschuk, Gary D ^b   Barbee, R Wayne ^a   Watts, John A ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; COENZYME A; ESTER; HYPNOTIC SEDATIVE AGENT; PENTOBARBITAL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; DRUG EFFECT; HEART; HEART FUNCTION TEST; HEMORRHAGIC SHOCK; HYPOTENSION; MALE; METABOLISM; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; COENZYME A; ESTERS; HEART; HEART FUNCTION TESTS; HYPNOTICS AND SEDATIVES; HYPOTENSION; MALE; PENTOBARBITAL; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, HEMORRHAGIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033258467     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199912000-00007     Document Type: Article

References (38)

1. Chang MC, Mondy SJ, Meredith JW, Holcroft JW. Redefining cardiovascular performance during resuscitation: ventricular stroke work, power and the pressure-volume diagram. J Trauma 45:470-478, 1998.
2. Siegel HW, Downing SE. Reduction of left ventricular contractility during acute hemorrhagic shock. Am J Physiol 218 (3):772-779, 1970.
3. Remmers DE, Ping Wang, Cioffi WG, Bland KI, Chaudry IH. Testosterone receptor blockade after trauma-hemorrhage improves cardiac and hepatic functions in males. Am J Physiol 273:H2919-H2925, 1997.
4. Chendrasekahar A, Barringer LS, Fagerli JC, Dulaney J, Pillai S, Timberlake GA. Load-independent left ventricular function in a hemorrhagic shock model. J Surg Res 62:49-52, 1996.
5. Regan TJ, LaForce FM, Teres D, Block J, Hellems HK. Contribution of left ventricle and small bowel in irreversible hemorrhagic shock. Am J Physiol 208:938-944, 1965.
6. MacDonald JAE, Milligan GF, Mellon A, Ledingham IM. Ventricular function in experimental hemorrhagic shock. Surg Gynecol Obstet 140: 572-581, 1975.
7. Lefer AM, Craddock GB, Cowgill R, Brand E. Performance of papillary muscles isolated from cats in postoligemic shock. Am J Physiol 211:687-692, 1966.
8. Horton JW. Hemorrhagic shock depresses myocardial contractile function in the guinea pig. Circulatory Shock 28:23-36, 1989.
9. Ratliff NB, Hackel DB. myocardial oxygen metabolism and myocardial blood flow in dogs in hemorrhagic shock. Circulation Research XXIV: 901-909, 1969.
10. Hackel DB, Goodale WT. Effects of hemorrhagic shock on the heart and circulation of intact dogs. Circulation 11:628-631, 1956.
11. Kline JA. Activation of pyruvate dehydrogenase improves heart function and metabolism after hemorrhagic shock. J Mol Cell Cardiol 29:2465-2474, 1997.
12. Edwards WS, Siegel A, Bing RJ. Studies on myocardial metabolism III. Coronary blood flow, myocardial oxygen consumption and carbohydrate metabolism in experimental hemorrhagic shock. J Clin Invest 1646-1661, 1954.
13. Bolukoglu H, Goodwin GW, Guthrie PH, Carmical SG. Metabolic fate of glucose in reversible low-flow ischemia of the isolated working rat heart. Am J Physiol 270:H817-H826, 1996.
14. Liu B, Clanachan AS, Schulz R, Lopaschuk GD. Cardiac efficiency is improved after ischemia by altering both the source and fate of protons. Circ Res 79:940-948, 1996.
15. Meldrum DR, Shenkar R, Sheridan BC, Cain BS, Abraham E, Harken AH. Hemorrhage activates myocardial NFkappaB and increases TNF-alpha in the heart. J Mol Cell Cardiol 29:2849-2854, 1997.
16. Demoz A, Garras A, Asiedu DK, Netteland B, Berge RK. Rapid method for the separation and detection of tissue short-chain coenzyme A esters by reversed-phase high-performance liquid chromatography. Journal of Chromatography 667:148-152, 1995.
17. Williamson JR, Corkey BE. Assays of intermediates of the citric acid cycle and related compounds by fluorometric enzyme methods. In Lowenstein JM, ed. Methods in Enzymology. 1 ed. New York: Academic Press, 1969:434-513.
18. Ogino R, Suzuki K, Kohno M, Nishina M, Kohama A. Effects of hypertonic saline and dextran 70 on cardiac contractility after hemorrhagic shock. J Trauma 44:59-69, 1998.
19. Siegel HW, Downing SE. Contributions of Coronary Perfusion Pressure, Metabolic Acidosis and Adrenergic Factors to the Reduction of Myocardial Contractility during Hemorrhagic Shock in the Cat. Circulation Research XXVII:875-889, 1970.
20. Elkins RC, McCurdy JR, Brown PP, Greenfield LJ. Effects of Coronary Perfusion Pressure on Myocardial Performance During Endotoxin Shock. Surgery, Gynecology & Obstetrics 137:991-996, 1973.
21. Barroso-Aranda J, Schmid-Schonbein GW, Zweifach BW, Engler RL. Granulocytes and no-reflow phenomenon in irreversible hemorrhagic shock. Circ Res 63:437-447, 1988.
22. Kapoor R, Prasad K. Role of polymorphonuclear leukocytes in cardiovascular depression and cellular injury in hemorrhagic shock and reinfusion. Free Radical Biology & Medicine 21:609-618, 1996.
23. Lefer AM. Role of a myocardial depressant factor in the pathogenesis of circulatory shock. Fed.Proc. 29:1836-1847, 1970.
24. Kengatharan M, Battistini B, Warner TD, Thiemermann C, Vane JR. Endothelin-1 mediates the increase in ex vivo coronary vascular resistance induced by hemorrhagic shock in the anesthetized rat. J Cardiovasc Pharmacol 26(suppl 3):s422-s424, 1995.
25. Kumar A, Venkateswarlu T, Dee L, Olson J, Uretz E, Parrillo JE. Tumor Necrosis Factor-α and Interleukin 1 are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183:949-958, 1996.
26. Zhao K-S, Junker D, Delano FA, Zweifach BW. Microvascular adjustments during irreversible hemorrhagic shock in rat skeletal muscle. Microvascular Research 30:143-153, 1985.
27. Poston JM, Parenteau GL. Biochemical effects of ischemia on isolated perfused rat heart tissues. Archives of Biochemistry and Biophysics 295: 35-41, 1992.
28. Idell-Wenger JA, Grotyohann LW, Neely JR. Coenzyme-A and carnitine distribution in normal and ischemic hearts. J Biol Chem 253:4310-4318, 1978.
29. Lopaschuk GD. Alterations in fatty acid oxidation during reperfusion of the heart after myocardial ischemia. Am J Cardiol 80:11A-16A, 1997.
30. Homans DC, Sublett E, Dai XZ, Bache R. Persistance of regional left ventricular dysfunction after exercise-induced myocardial ischemia. J Clin Invest 77:66-73, 1985.
31. Ferrari R, Cargnoni A, Bernocchi P, et al. Metabolic adaptation during a sequence of no-flow and low-flow ischemia. A possible trigger for hibernation. Circulation 94:2587-2596, 1996.
32. Park S-W, Tang X-L, Qiu Y, Sun J-Z, Bolli R. Nisoldipine attenuates myocardial stunning induced by multiple coronary occlusions in conscious pigs and this effect is independent of changes in hemodynamics or coronary blood flow. J Mol Cell Cardiol 28:655-666, 1995.
33. Arai AE, Grauer SE, Anselone CG, Pantely GA, Bristow JD. Metabolic adaptation to a gradual reduction in myocardial blood flow. Circulation 92:244-252, 1995.
34. Bolli R. mechanism of myocardial 'stunning'. Circulation 82:723-738, 1990.
35. Mjos OD. Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs. J Clin Invest 50:1386-1389, 1971.
36. Segal J. Effect of anesthesia on cardiac function and response in the perfused rat heart. J Mol Cell Cardiol 22:1317-1324, 1990.
37. Rubaynyi G, Kovach AGB. Effect of pentobarbital anesthesia on contractile performance and oxygen-consumption of perfused rat heart. Circ Shock 7:121-127, 1980.
38. Weiss, JP, Barlow, CH, Chance, B. Peritobarbital-induced reduction of pyridine nucleotide measured by surface fluorometry in perfused rat heart. Biochemical Pharmacology 27:1510-511, 1977.